Do Similar Amphetamine Metabolites Mean Equal Effects Across Species?

Similar metabolite patterns do not establish equivalent drug effects. A 2014 psychostimulant review describes a radiolabeled amphetamine comparison in which humans, monkeys and greyhounds had similar metabolic profiles, while several other species differed. The study used different doses and administration routes and did not establish whether the regimens produced comparable behavior.

That distinction matters when animal research is used to explain human toxicology. A finding about the products of metabolism cannot, by itself, determine a human dose, blood concentration, cognitive effect or impairment threshold.

What kind of source is this?

Wood and colleagues reviewed psychostimulant effects on cognition, including evidence involving amphetamine, cocaine, methylphenidate, modafinil and caffeine. Their discussion separates pharmacokinetics—the processes governing exposure and elimination—from pharmacodynamics, the interaction between a drug and its biological targets.

The cross-species example comes from a 1970 study by Dring and colleagues as summarized in that supplied review. It is historical comparative research, not a new experiment performed for this article. The primary study’s participant and animal counts, sampling schedule and uncertainty estimates are not provided in the review’s short account; no common denominator or confidence interval is inferred here.

Which doses and routes were compared?

The review describes radiolabeled amphetamine metabolism measured through metabolites in urine and feces. Its account reports the following regimens. These are administered amounts, not concentrations measured in specimens.

The human 5-mg figure is a total dose, whereas the other listed quantities are normalized to body weight. The approximate human mg/kg expression is part of the review’s comparison; it should not be treated as a directly measured concentration or an exact conversion for every person.

The review identifies the compound as radiolabeled amphetamine in this passage. Its summary does not resolve every chemical-form or enantiomer detail needed to reconstruct the original protocol, so the table does not add those specifications.

What was similar, and what differed?

The review reports similar metabolic profiles in monkeys, greyhounds and humans, with different profiles in rats, rabbits, guinea pigs and mice. This concerns patterns of metabolism and elimination in the studied conditions.

It does not mean that every metabolite concentration was identical, that elimination proceeded at the same speed or that all species experienced the same brain exposure. “Similar profile” should retain the limited meaning supported by the summary rather than becoming a claim of complete pharmacological equivalence.

Why do the unequal doses limit interpretation?

Species and dose were not independently matched in the reported comparison. The regimens also combined oral administration with intraperitoneal injection. An observed difference therefore cannot automatically be assigned solely to species biology; the dosing and route differences must remain part of the account.

Conversely, a similar profile despite unequal regimens does not validate those regimens as equivalent. To establish equivalence of exposure, investigators would need appropriately defined exposure measurements and a comparison designed to answer that question.

Wood and colleagues specifically note the absence of measures establishing whether the different doses produced notable behavioral differences between species. The metabolic comparison therefore does not supply the functional bridge that a claim of equal cognitive or motor effects would require.

Can body-weight scaling solve the problem?

The review discusses body-weight and allometric approaches to dose comparison, while emphasizing that their usefulness varies with the compound, metabolism and elimination. A conversion rule is an assumption about comparability, not a measurement of the resulting exposure.

Even an identical mg/kg dose across species would not, on its own, establish an identical concentration–time course. Here the reported mg/kg doses were not identical in the first place. Selecting one number from this study and scaling it to a client’s weight would not reconstruct that person’s dose or drug level.

Would matched plasma concentrations establish matched effects?

They would address a closer exposure question, but not every pharmacodynamic question. The review emphasizes that plasma measurements do not reveal drug potency at the synapse or fully describe where and how successfully a drug interacts with its targets. Receptor distribution and physiological response can differ between species.

Urine and fecal metabolite patterns are an additional step removed from a direct demonstration of brain activity or task performance. Their scientific value should not be confused with the different value of serial plasma sampling, receptor measurements or controlled behavioral testing.

What is the practical forensic lesson?

Identify the administered substance, dose units, route, specimen, collection interval and endpoint before translating an animal result into a human explanation. A metabolism study may help frame hypotheses about elimination without validating a behavioral or impairment conclusion.

This historical example cannot establish that a person was impaired because their specimen contained amphetamine or a metabolite. Nor can it establish lack of impairment because an animal’s elimination profile resembled a human profile. Those claims require human and case-specific evidence matched to the question being asked.

Scientific source

Wood S, Sage JR, Shuman T, Anagnostaras SG. Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation. Pharmacological Reviews. 2014;66(1):193–221. doi:10.1124/pr.112.007054. Full-text review. Historical narrative review. The Dring et al. comparison above is discussed through its pharmacokinetics section, not represented as an independently reanalyzed primary experiment.